baber/WOPTO huggingface dataset:
Patent NZ-223663-A (NZ)
Title: 2,3-dihydro-2-oxobenzofuran-3-ylacetic acid derivatives, preparatory processes and pharmaceutical compositions
Inventor: LAVIELLE G
IPC: C07D307/83
Filed: 1988-02-26
Abstract: The invention relates to new 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acid compounds of general formula I:    <IMAGE>  (I)  in which: R1 denotes a hydrogen atom, a linear or branched alkyl radical having 1 to 4 carbon atoms or a phenyl radical optionally substituted with a halogen atom or with an alkoxy radical containing 1 to 4 carbon atoms or an alkyl radical having 1 to 4 carbon atoms, R2 denotes a hydrogen or halogen atom, a hydroxyl radical, an alkyl radical having 1 to 4 carbon atoms or an alkoxy radical containing 1 to 4 carbon atoms, R denotes a hydroxyl radical, a linear or branched alkoxy radical having 1 to 4 carbon atoms, a benzyloxy radical or a radical of general formula A: <IMAGE> (A)  in which: X and Y, which may be identical or different, each denote a linear or branched alkyl radical containing 1 to 5 carbon atoms, a radical of general formula A1 (CHZ-COOH)-, in which Z denotes a hydrogen atom, a linear or branched alkyl radical having 1 to 4 carbon atoms, a hydroxyalkyl radical having 1 to 4 carbon atoms, a 4-imidazolylmethylene radical or a benzyl radical optionally substituted with an alkyl radical having 1 to 4 carbon atoms or with a hydroxyl radical; a radical of general formula A2 (CH2W)-in which W denotes a linear or branched dialkylaminomethylene radical having 3 to 9 carbon atoms, a 2-pyrrolidinyl radical optionally substituted with an alkyl radical having 1 to 4 carbon atoms, a benzyl radical, a 1-isochromanyl radical or a 1-isoquinolyl radical, or form, together with the nitrogen to which they are attached, a 2-carboxy-2-pyrrolidinyl radical, a 4-morpholinyl radical, a piperidino radical optionally substituted with a phenyl radical or with an alkoxyphenyl radical having 7 to 10 carbon atoms, or a 1-piperazinly radical.
Patent NZ-230801-A (NZ)
Title: Displacement control of a multi-piston pump with solenoid actuable poppet valves
Inventor: SALTER STEPHEN HUGH
IPC: F04B7/00
Filed: 1989-09-27
Abstract: Displacement control of a multi-piston fluid pump (30) is achieved by real time control of electrically selectable inlet poppet valves (36) in one or more of the cylinders (34). Microprocessor (40) control permits desired variable output characteristics to be matched. An electrically actuable poppet valve using an annular permanent magnet to latch to a solenoid is described.
Patent NZ-232047-A (NZ)
Title: Production of ceramic bodies, comprising a metal boride and having graded porosity, from particulate metal and boron carbide
Inventor: CLAAR TERRY DENNIS
IPC: H01B17/64
Filed: 1990-01-08
Abstract: This invention relates generally to a novel method of preparing self-supporting bodies and to the novel products made thereby. In its more specific aspects, this invention relates to a method of producing self-supporting bodies comprising one or more boron-containing compounds, e.g., a boride or a boride and a carbide, by reacting, in one embodiment, a powdered parent metal, in molten form, with a bed or mass comprising a boron carbide material and, optionally, one or more inert fillers, to form the body. In another embodiment, both of a powdered parent metal and a body or pool of molten parent metal are induced to react with a bed or mass comprising a boron carbide material, and, optionally, one or more inert fillers.
Patent NZ-236521-A (NZ)
Title: Phase jitter reduction in phase locked loop with non-integral frequency division
Inventor: DENT PAUL WILKINSON
IPC: H03L7/089
Filed: 1990-12-18
Abstract: The present invention relates to frequency synthesis with a controlled oscillator (20) included in a phase locked loop, where the frequency of the oscillator output signal is divided (22) periodically by different integers, such that the frequency is, on average, divided by a value which is equal to an integer N plus or minus a numeric fraction whose absolute value is smaller than one. The phase position of pulses formed in this way is compared with the phase position of pulses which derive from a reference signal (10, 12), therewith forming a phase error signal. For the purpose of suppressing periodic variations of an oscillator control signal as a result of phase jitter, there is added or subtracted to the phase error signal, in a known manner, a correction value (24, 26) which is dependent on the aforementioned numeric fraction. In order to eliminate the need to multiply the correction value by a factor which is proportional to the inverted value of the integer N, the phase error signal is instead amplified with a factor N (28) prior to adding or subtracting the correction value. The loop bandwidth is also held constant in this way. <IMAGE>
Patent NZ-258702-A (NZ)
Title: Phosphating compositions, method for providing phosphate conversion coating on metal substrate, and use in the fabrication of printed circuits utilising organic resins
Inventor: LARSON GARY B
IPC: C23C22/42
Filed: 1993-11-15
Abstract: Composition and methods for providing a phosphate conversion coating on a metal surface, particularly a copper surface, characterized in that the phosphating composition includes at least one composition-soluble compound containing vanadium, niobium, tungsten or tantalum. The phosphate conversion coatings so produced are thicker, more durable and more uniform than those produced by known phosphating compositions. The compositions and processes are especially useful for providing a passivating/uniformizing coating layer on copper surfaces to which organic resin is thereafter deposited to serve as a resist in printed circuit fabrication sequences, particularly when the organic resin is an electrophoretically deposited organic resin. Also described is the microetching of copper surfaces with a phosphoric acid/peroxide microetchant preparatory to deposit thereon (or after a further provision of a phosphate conversion coating) of a photoresist which is then imagewise exposed and developed to provide a patterned resist.
Patent NZ-260660-A (NZ)
Title: Benzoylguanidine derivatives and medicaments thereof
Inventor: LANG HANS-JOCHEN
IPC: C07C323/62
Filed: 1994-06-02
Abstract: There are described benzoylguanidines of the formula I <IMAGE>  where   R(1) is H, Hal, -NO2, -C IDENTICAL N, Xo-(CH2)p-(CF2)q-CF3, R(5)- SOm, R(6)-CO- or R(6)R(7)NO-SO2-, where X is O, S, NR(14), m is 0-2, o is 0, 1, p is 0-2, q is 0-6, R(5) and R(6) are alk(en)yl, -CnH2n-R(8), CF3, n is 0-4, R(8) is cycloalkyl, phenyl, R(6) also being H,   R(2) is <IMAGE> where Y is O, -S- or -NR(12)-; R(11), R(12) = H, alkyl, and h is zero or 1, and i, j and k are 0-4,  but where h, i and k are not simultaneously zero, R(3) is defined as R(1), or is alkyl, -X-R(13) where X is O, S, NR(14), R(14) is H, alkyl, R(13) is H, (cyclo)alkyl, -CbH2b-R(15) where b is 0-4,  R(15) is phenyl,   R(4) is H, -OR(16) or -NR(16)R(17) where R(16), R(17) are H, alkyl  and their pharmaceutically tolerable salts. They are obtained from a compound II <IMAGE> by reaction with guanidine, in which R(1) to R(4) have the meaning indicated and L is a leaving group which can be easily nucleophilically substituted. The compounds are outstandingly suitable as antiarrhythmic medicaments having a cardioprotective component for infarct prophylaxis and infarct treatment and also for the treatment of angina pectoris, where they also preventively inhibit or severely decrease the pathophysiological processes in the formation of ischaemically induced damage, in particular in the elicitation of ischaemically induced cardiac arrhythmias.
Patent NZ-266552-A (NZ)
Title: Communications system: dynamic control of mobile transmitter power and base receiver attenuation
Inventor: BORG LARS UNO
IPC: H04B7/005
Filed: 1994-05-10
Abstract: A communications system includes a receiver and a transmitter for transmitting a communications signal to the receiver. The transmitter adjusts its transmission power level in response to receiver power control signals transmitted by the receiver. The receiver includes an attenuator for attenuating the received communications signal, and measurement circuitry for measuring the signal strength of the attenuated signal. The measured signal strength is coupled to an attenuator controller and to a transmission power controller. The attenuator controller and the transmission controller adjust, respectively, receiver attenuation and transmitter power level so as to optimize system performance. This may include keeping the attenuated signal within the dynamic range of the receiver. This may also include eliminating disturbance signals by adjusting receiver attenuation to produce an effective dynamic range for receiving only signals having a signal strength level that is higher than the disturbance signal strength level, while at the same time increasing the transmission power level to keep it within the effective dynamic range of the receiver. The disturbance signal may be detected as an increased bit error rate of the received communication signal. The apparatus and method may also be applied to systems in which a plurality of receivers are coupled to a common antenna through a receiver multicoupler.
Patent NZ-322796-A (NZ)
Title: An apoptotic cysteine protease, mch3 which is a member of ice proteases and nucleic acids encoding mch3
Inventor: ALNEMRI EMAD S
IPC: C12N15/09
Filed: 1996-11-12
Abstract: The invention provides an isolated gene encoding Mch3, or functional fragment thereof. Also provided is an isolated nucleic acid sequence encoding Mch3 or functional fragment thereof. The gene or nucleic acid sequence can be single or double stranded nucleic acids corresponding to coding or non-coding strands of the Mch3 nucleotide sequence. An isolated Mch3 polypeptide or functional fragment thereof is also provided.
Patent NZ-326266-A (NZ)
Title: Genomic polyphenyl oxidase (PPO) clones
Inventor: ROBINSON SIMON PIERS
IPC: C12N9/02
Filed: 1997-01-24
Abstract: The application relates to the isolation of genes encoding polyphenol oxidase (PPO) from plants.  In a first aspect there is provided a method for preparing nucleic acid encoding PPO, fragments and derivatives thereof, which method includes providing a sample of plant tissue, a first primer in sense orientation having a sequence corresponding to a conserved region of a PPO gene, a second primer in antisense orientation having a sequence corresponding to a conserved region of a PPO gene; isolating genomic DNA from the plant tissue; and amplifying the genomic DNA using the first and second primers. The applicant has found that PPO genes in plants lack introns and, therefore, fragments of PPO genes may be amplified directly from genomic DNA of a range of plants.  The lack of introns means that the size of the fragments can be predicted and bands of the appropriate size can be selected for cloning.
Patent NZ-329997-A (NZ)
Title: Pressure swing adsorption apparatus and process using two vessels, charging and scavenging pump, and a reservoir, with components being interconnected in various combinations at stages of process
Inventor: DOONG SHAIN-JER
IPC: B01D53/04
Filed: 1998-03-19
Abstract: he process is depicted in the steps 2A to 2I with steps 2B, 2F and 2I being optional.  Co-current flow through vessels A and B is upwards, with counter-current flow downwards.  Appropriate lines and valves are provided, typically being lines 2 to 58 and valves 4 to 56.
Patent NZ-331800-A (NZ)
Title: Zeolite dispersion
Inventor: CRUSLOCK YLVA
IPC: D04H1/40
Filed: 1997-03-21
Abstract: An aqueous dispersion comprises particles of a zeolite having a hydrophobicity of below about 0.9 percent by weight residual butanol as determined by the Residual Butanol Test, which dispersion comprises a stabilising amount of a biogum.  Production of the dispersion comprises mixing zeolite particles with a biogum into a dry mixture; and mixing the dry mixture with water under agitation into a homogeneous mixture.  The dispersion is used for binding particles of zeolite to fibres. Production of paper or paperboard by forming and dewatering a suspension of cellulosic fibres is disclosed wherein dewatering is carried out in the presence of particles of a zeolite, the dispersion being added to the suspension prior to dewatering.  Production of dry-laid paper, nonwoven or fluff pulp, is described in which cellulosic fibres are carried by a gas stream, and in which the dispersion is sprayed onto the fibres while they are carried by the gas stream.
Patent NZ-332323-A (NZ)
Title: Chromatographic method for removing unconventional transmissible agents from a protein solution
Inventor: GRANDGEORGE MICHEL
IPC: B01D15/08
Filed: 1997-03-14
Abstract: The present invention is drawn to method for removing unconventional transmissible agents (UCTA) from aqueous protein solution. This method involves treating the aqueous protein solution with simultaneous electrostatic adsorption and hydrophobic chromatography. The method of the present invention is particularly suitable for treating calf serum or an albumin solution.
Patent NZ-332975-A (NZ)
Title: Combinatorial synthesis of carbohydrate libraries
Inventor: HINDSGAUL OLE
IPC: C07H15/18
Filed: 1997-11-14
Abstract: Provided are general synthetic methods for generating very large libraries of diverse thiosaccharide derivatives optionally attached to a solid support. The thiosaccharide derivative libraries are synthesized by reacting a thiosaccharide with a Michael acceptor or an a-halocarbonyl compound (Q-CHR1-C(O) R ) to provide for a thiosaccharide carbonyl compound. The carbonyl group of the thiosaccharide carbonyl compound can optionally be reduced to provide for a plurality of alcohol and/or amine thiosaccharide derivatives. In one embodiment, the alcohol and/or amine group of the thiosaccharide derivative is further derivatized to provide for a plurality of thiosaccharide derivatives. Preferably,  the thiosaccharide derivatives are covalently attached to a solid support. Solid supports containing such thiosaccharide derivatives comprise a linking arm which links the solid support to the thiosaccharide derivative. The linking arm can be either cleavable or non-cleavable and when cleavable, can be used to prepare a library of either solid phase or soluble thiosaccharide derivatives. The library of thiosaccharide derivatives, whether soluble or insoluble, can be screened to isolate individual compounds that possess some desired biological activity. In a preferred embodiment, each compound in the library is unique. Figure 1 illustrates a preferred reaction scheme for synthesizing a library of diverse thiosaccharide derivatives using an a,b-unsaturated carbonyl compound, such as cyclohept-2-en- 1-one.
Patent NZ-335327-A (NZ)
Title: Mouse cardiac muscle cell line, HL-1
Inventor: CLAYCOMB WILLIAM CREIGHTON
IPC: C12N5/077
Filed: 1997-10-24
Abstract: The application relates to a cell line ("HL-1") derived from a transplantable mouse cardiomyocyte lineage (AT-1) wherein the cell line has the following characteristics: a) can be serially passaged greater than two hundred times and retain the ability to spontaneously contract; b) can be frozen, stored in, and recovered from liquid nitrogen, and revived upon thawing; c) can be cultured in serum-free medium; d) retains ultrastructural characteristics of in vitro adult atrial cardiac muscle cells; e) displays a pattern of gene expression similar to that of adult atrial myocytes including ANF, atrial natriuretic factor, a-cardiac myosin heavy chain, a-cardiac actin and connexin43; f) responds positively to immunohistochemical stains for desmin, sarcomeric myosin, and atrial natriuretic peptide; g) will give rise to tumors when injected subcutaneously into syngeneic mice h) can secrete into the culture medium growth factors including basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), epithelial growth factor (EGF), transforming growth factor beta 1(TGF-b1), and adrenomedullin; i) displays a cardiac-like, rapidly activating and inactivating delayed rectifier potassium current with biophysical and pharmacological characteristics that are nearly identical to those described for cardiac Ikr, j) displays time- and voltage-dependent inward currents that are most likely sodium and L-type calcium currents. The application further relates to a cell culture system which can be used as an in vitro model of the cardiac muscle cell to screen and test cardiac drugs.
Patent NZ-336729-A (NZ)
Title: Process for transesterifying alpha-ketocarboxylic esters
Inventor: ZIMMERMANN CURT
IPC: C07C67/03
Filed: 1999-07-13
Abstract: A process for transesterifying alpha-ketocaboxylic esters comprising carrying out the transesterification in an anhydrous alcohol reaction medium in the presence of tin, titanium, zirconium, lithium or acetylacetonate catalysts.
Patent NZ-337997-A (NZ)
Title: A tangent folder for folding sheet metal
Inventor: GOOD CHRISTOPHER ARTHUR
IPC: B21D5/00
Filed: 1999-09-23
Abstract: A tangent folder includes a main member (2) and a sheet contacting secondary member (4) connected to the main member by a translational allowing interface (5), which at least retains the orientation of the secondary member relative to the main member and a secondary member guide means (6), which control the translational position of the secondary member relative to the main member according to the orientation and/or location of the secondary member.
Patent NZ-500365-A (NZ)
Title: Rectangular panel for a container divided into at least three panel parts with one part for forming top and other two for forming front
Inventor: BONNER CRAIG RONALD
IPC: B65D25/54
Filed: 1999-10-18
Abstract: Panel 1 is formed of rectangular self-supporting material, typically fluted cardboard. The panel consists of at least three portions: top 17 and two front parts 15, 16. Parallel fold lines 10,11,12 are formed so that passageways 5 are continuous after folding to the use positions. The front panel is readily foldable back to allow inspection and re-closing.
Patent NZ-504707-A (NZ)
Title: 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
Inventor: GILBERT SHERI ANN
IPC: A61P25/06
Filed: 1998-11-20
Abstract: A compound of formula (I), its tautomers or salts or biohydrolyzable esters, amides, or imides, wherein: R1 is alkyl; R2 is hydrogen, alkyl, methoxy, cyano, and halo; R3 is hydrogen, methyl, hydroxy, cyano and halo; R4 is hydrogen, methyl, ethyl and isopropyl; R5 is hydrogen, methyl, amino, methoxy, hydroxy, cyano and halo; provided that at least one of R2, R3, or R5 is other than hydrogen or fluorine; provided that when R1 is methyl and both R2 and R5 are hydrogen, R3 is other than methyl or halo; provided that when R3 is cyano, R1 is methyl; and The compounds of formula (I) are peripherally acting selective alpha-2 adrenergic compounds that reduce CNS activity and that resist metabolic transformation into undesirable compounds.
Patent NZ-507916-A (NZ)
Title: Method for detecting delayed data frames in a transport function
Inventor: REZAIIFAR RAMIN
IPC: H04L29/06
Filed: 1999-05-19
Abstract: A method for detecting delayed data frames in a transport function includes the steps of comparing a frame sequence counter with a predetermined threshold value (304), detecting a delayed frame if the sequence counter exceeds the threshold value, and processing the detected delayed frame accordingly (306). In an RLP data transport protocol, the delayed frame may be processed as a retransmitted frame. The threshold value may be proportional to the maximum number of frames sent in a given bundle times the maximum delay, in units of frame intervals, between frames sent simultaneously over the air in the same frame interval.
Patent NZ-508811-A (NZ)
Title: Telecommunications patch panel with angled connector modules rotatably mounted in a frame member
Inventor: FOLLINGSTAD MICHAEL JAY
IPC: H01R13/518
Filed: 1999-05-20
Abstract: A combination infrared/air convection dryer or oven for travelling webs. A shutter assembly is provided between the infrared radiation source and the moving web in order to selectively expose the web to infrared radiation, and to create a sealed air chamber when in the closed position. Enhanced drying of the web and/or a coating on the web at high speed is achieved without a concomitant increase in dryer length. When the drying atmosphere has a high concentration of solvent, exposure of that atmosphere to the heating elements, which can cause explosions, is eliminated by actuation of the shutters. In a preferred embodiment of the invention, air bars are used to floatingly support the moving web to avoid contact of the web with dryer elements.
Patent NZ-510250-A (NZ)
Title: Shaping tool for information carrier disc blanks having a die orifice of less than 0.3mm and a die clearance of 0.2mm
Inventor: HOSS WERNER
IPC: G11B7/24
Filed: 1999-09-15
Abstract: The invention relates to a shaping tool for the injection molding or injection compression of information carrier disc blanks (11) made of polymethacrylate plastic which is suited as a component of an injection molding or injection compression machine. The shaping tool is comprised of two mold parts (1, 2), whereby one mold part (1) contains a bottom part (8) of a mold with the information data and, together with the second mold part (2), forms a cavity for the one information carrier blank and one sprue bush (4) for a sprue piece (5) in the tool having a concentrically positioned feed orifice (6). In addition, the tool comprises a impact cylinder (9) for shearing the sprue piece (5) and has an ejector pin (10). The invention is characterized in that the injection gap (SP) between the feed orifice (6) of the sprue piece (5) and the information carrier disc blank (11) is less than 0.3 mm. In addition, the cutting gap (SN) between the edge of the impact cylinder (9) and the information carrier disc blank (11) is less than 0.2 mm.
Patent NZ-510759-A (NZ)
Title: An indirectly activated closure
Inventor: ZAKSENBERG ISAAC
IPC: B65D47/08
Filed: 1999-09-23
Abstract: The present closure is one that is actuated and opened indirectly.  A force on a push pad (18) causes the lid  (25) to  open.   There is no direct manual force applied  to  the lid  to  open the lid.  The closure is comprised of  a  base section  (31)  and a lid section (25).  These  are  separate molded   sections.   These  separate  molded  sections   are attached   after   molding.   The  base  section   has   the attachment  (14)  to  a container, structural  integrity,  a spout  (28), and a lid actuator mechanism.  The lid actuator mechanism is comprised of a strap (16) with a push pad  (18) with  an  actuator rod (21) at the end adjacent an  actuator wall  (23).   The  lid  section (25)  has  a  spout  closing section  for the spout of the base section and an attachment fitting (42) for attachment to the base section.  The  spout closing  section  is attached to the attachment  fitting  by living  hinges  (24, 26), and preferably,  preloaded  living hinges.   Such  living hinges reduce the force  to  actuate. The  closure is opened by pushing on a push pad  (18)  which in  turn causes the living hinges to be actuated and the lid snap opened.  The lid is manually closed.
Patent NZ-513901-A (NZ)
Title: Pharmaceutical kit comprises an immobilized and activity-stabilized complex of LHRH antagonist with a polyamino acid for treating hormone sensitive tumours and fertility disorders.
Inventor: MURGAS SANDRA
IPC: A61K38/09
Filed: 1998-03-11
Abstract: A pharmaceutical kit comprises a complex between a LHRH antagonist selected from antide, antarelix, azaline, A-75998, ganirelix, Nal-Glu antagonist and cetrorelix and a polyamino acid selected from polyglutamic acid and polyaspartic acid for treating a hormone sensitive tumour, benign prostate hypertrophy, a fertility disorder or endometriosis".